These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36951032)

  • 61. Bivalent activity of super-enhancer RNA LINC02454 controls 3D chromatin structure and regulates glioma sensitivity to temozolomide.
    Shi T; Guo D; Zheng Y; Wang W; Bi J; He A; Fan S; Su G; Zhao X; Zhao Z; Song Y; Sun S; Li P; Zhao Z; Shi J; Lu W; Zhang L
    Cell Death Dis; 2024 Jan; 15(1):6. PubMed ID: 38177123
    [TBL] [Abstract][Full Text] [Related]  

  • 62. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CD147 confers temozolomide resistance of glioma cells via the regulation of β-TrCP/Nrf2 pathway.
    Bu X; Qu X; Guo K; Meng X; Yang X; Huang Q; Dou W; Feng L; Wei X; Gao J; Sun W; Chao M; Han L; Hu Y; Shen L; Zhang J; Wang L
    Int J Biol Sci; 2021; 17(12):3013-3023. PubMed ID: 34421346
    [No Abstract]   [Full Text] [Related]  

  • 64. FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β-catenin nuclear accumulation.
    Xu K; Zhang Z; Pei H; Wang H; Li L; Xia Q
    Oncol Rep; 2017 Apr; 37(4):2391-2397. PubMed ID: 28260024
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine.
    Stritzelberger J; Distel L; Buslei R; Fietkau R; Putz F
    Clin Transl Oncol; 2018 Apr; 20(4):508-516. PubMed ID: 28825189
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thymoquinone induces apoptosis in temozolomide-resistant glioblastoma cells via the p38 mitogen-activated protein kinase signaling pathway.
    Mai A; Ye SW; Tu JY; Gao J; Kang ZF; Yao QM; Ting WJ
    Environ Toxicol; 2023 Jan; 38(1):90-100. PubMed ID: 36176197
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gene expression profiling predicts response to temozolomide in malignant gliomas.
    Yoshino A; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Naruse N; Sano E; Tsumoto K
    Int J Oncol; 2010 Jun; 36(6):1367-77. PubMed ID: 20428759
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells.
    Qiu ZK; Shen D; Chen YS; Yang QY; Guo CC; Feng BH; Chen ZP
    Chin J Cancer; 2014 Feb; 33(2):115-22. PubMed ID: 23958055
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance.
    Ma J; Murphy M; O'Dwyer PJ; Berman E; Reed K; Gallo JM
    Biochem Pharmacol; 2002 Apr; 63(7):1219-28. PubMed ID: 11960598
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Exosomes released from U87 glioma cells treated with curcumin and/or temozolomide produce apoptosis in naive U87 cells.
    Mousavi SM; Hosseindoost S; Mahdian SMA; Vousooghi N; Rajabi A; Jafari A; Ostadian A; Hamblin MR; Hadjighassem M; Mirzaei H
    Pathol Res Pract; 2023 May; 245():154427. PubMed ID: 37028110
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.
    Ulasov I; Thaci B; Sarvaiya P; Yi R; Guo D; Auffinger B; Pytel P; Zhang L; Kim CK; Borovjagin A; Dey M; Han Y; Baryshnikov AY; Lesniak MS
    Cancer Med; 2013 Aug; 2(4):457-67. PubMed ID: 24156018
    [TBL] [Abstract][Full Text] [Related]  

  • 72. PSMG3-AS1 enhances glioma resistance to temozolomide via stabilizing c-Myc in the nucleus.
    Zhou L; Huang X; Zhang Y; Wang J; Li H; Huang H
    Brain Behav; 2022 May; 12(5):e2531. PubMed ID: 35380741
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CCL2 activates AKT signaling to promote glycolysis and chemoresistance in glioma cells.
    Qian Y; Ding P; Xu J; Nie X; Lu B
    Cell Biol Int; 2022 May; 46(5):819-828. PubMed ID: 35178826
    [TBL] [Abstract][Full Text] [Related]  

  • 74. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
    Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
    J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ZNF300 enhances temozolomide resistance in gliomas by regulating lncRNA SNHG12.
    Fu J; Peng J; Tu G
    Gen Physiol Biophys; 2022 Jul; 41(4):349-355. PubMed ID: 35938968
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ceramide Is Involved in Temozolomide Resistance in Human Glioblastoma U87MG Overexpressing EGFR.
    Bassi R; Dei Cas M; Tringali C; Compostella F; Paroni R; Giussani P
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895074
    [TBL] [Abstract][Full Text] [Related]  

  • 77. GADD45A plays a protective role against temozolomide treatment in glioblastoma cells.
    Wang HH; Chang TY; Lin WC; Wei KC; Shin JW
    Sci Rep; 2017 Aug; 7(1):8814. PubMed ID: 28821714
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Overexpression of ILK promotes temozolomide resistance in glioma cells.
    Liang F; Wang B; Bao L; Zhao YS; Zhang SM; Zhang SQ
    Mol Med Rep; 2017 Mar; 15(3):1297-1304. PubMed ID: 28138714
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide.
    Kanzawa T; Bedwell J; Kondo Y; Kondo S; Germano IM
    J Neurosurg; 2003 Dec; 99(6):1047-52. PubMed ID: 14705733
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27.
    Sang DP; Li RJ; Lan Q
    Acta Pharmacol Sin; 2014 Jun; 35(6):832-8. PubMed ID: 24902789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.